Featured Research

from universities, journals, and other organizations

Gimmick-free weight-loss pill in the works

Date:
January 27, 2010
Source:
University of Montreal
Summary:
A Canadian research team is developing a pill composed of leptin, the protein that tells our brain to stop eating.

A Université de Montréal research team is developing a pill composed of leptin, the protein that tells our brain to stop eating.

"Mice deprived of leptin will not stop eating. They become so big they have trouble moving around," says Moïse Bendayan, a pathology professor at the Université de Montréal Faculty of Medicine who has studied the leptin protein extensively.

Leptin regulates appetite in mammals and its levels decrease when fasting and rise during meals. It has been proven to be an appetite suppressant when administered intravenously to pathologically obese people.

Postdoctoral student Philippe Cammisotto is leading the charge for a leptin-based, appetite suppressing pill with Dr. Bendayan and Émile Levy, a professor from the Department of Nutrition. "Taken orally, such a pill would provide obese people with the sensation of being full. They would eat less and in turn lose weight," says Dr. Cammisotto.

"We hope to start animal testing in 2010," says Bendayan. "The molecule is easy to synthesize and the protocol is ready."

After decades of building his reputation in fundamental research, Bendayan is happy to collaborate on something more tangible. "Obesity is a big problem in our society, no pun intended," says Bendayan. "To develop medication to combat obesity would be a great way for our laboratory to contribute to public health."

The new pill is being created based on a startling Université de Montréal discovery from 2006: leptin isn't only secreted by fatty tissues. "From the first bite of any meal, leptin levels skyrocket in the bloodstream. Yet this has nothing to do with the leptin stored in the fatty tissues," says Bendayan. "In the lab, we proved that up to 80 percent of cells in our stomach also produce leptin. Those are the ones that regulate appetite."

The Université de Montréal finding led to a different understanding of how the protein works, since leptin alone can't survive in an acidic stomach without assistance. Indeed, leptin protects itself with an accomplice that acts as its bodyguard and accompanies the protein through the digestive system until it can be absorbed into the bloodstream.


Story Source:

The above story is based on materials provided by University of Montreal. Note: Materials may be edited for content and length.


Cite This Page:

University of Montreal. "Gimmick-free weight-loss pill in the works." ScienceDaily. ScienceDaily, 27 January 2010. <www.sciencedaily.com/releases/2010/01/100126111951.htm>.
University of Montreal. (2010, January 27). Gimmick-free weight-loss pill in the works. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/01/100126111951.htm
University of Montreal. "Gimmick-free weight-loss pill in the works." ScienceDaily. www.sciencedaily.com/releases/2010/01/100126111951.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins